OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Association of nirmatrelvir for acute SARS‐CoV‐2 infection with subsequent Long COVID symptoms in an observational cohort study
Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 27
Matthew S. Durstenfeld, Michael J. Peluso, Feng Lin, et al.
Journal of Medical Virology (2024) Vol. 96, Iss. 1
Open Access | Times Cited: 27
Showing 1-25 of 27 citing articles:
Mechanisms of long COVID and the path toward therapeutics
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Michael J. Peluso, Steven G. Deeks
Cell (2024)
Open Access | Times Cited: 23
Association of nirmatrelvir–ritonavir with post-acute sequelae and mortality in patients admitted to hospital with COVID-19: a retrospective cohort study
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Huwen Wang, Yuchen Wei, C.T. Hung, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1130-1140
Open Access | Times Cited: 13
Exploring the Complexities of Long COVID
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 8
Jackson Donald, Shymaa E. Bilasy, Catherine Yang, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1060-1060
Open Access | Times Cited: 8
Early biological markers of post-acute sequelae of SARS-CoV-2 infection
Scott Lu, Michael J. Peluso, David V. Glidden, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Scott Lu, Michael J. Peluso, David V. Glidden, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
The efficacy of antivirals, corticosteroids, and monoclonal antibodies as acute COVID-19 treatments in reducing the incidence of long COVID: a systematic review and meta-analysis
Gangqiang Sun, Ke Lin, Jingwen Ai, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1505-1513
Closed Access | Times Cited: 5
Gangqiang Sun, Ke Lin, Jingwen Ai, et al.
Clinical Microbiology and Infection (2024) Vol. 30, Iss. 12, pp. 1505-1513
Closed Access | Times Cited: 5
Long Covid in Older Adults: Functional Outcomes and Treatment Effectiveness
Brittin Wagner, Kate Mathers, Aaron Norfolk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Brittin Wagner, Kate Mathers, Aaron Norfolk, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Neurological sequelae of long COVID: a comprehensive review of diagnostic imaging, underlying mechanisms, and potential therapeutics
Grant Talkington, Paresh Kolluru, Timothy E. Gressett, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Grant Talkington, Paresh Kolluru, Timothy E. Gressett, et al.
Frontiers in Neurology (2025) Vol. 15
Open Access
Serum Spike Protein Persistence Post COVID Is Not Associated with ME/CFS
Annick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1086-1086
Open Access
Annick Fehrer, Franziska Sotzny, Laura Kim, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 4, pp. 1086-1086
Open Access
Effectiveness of nirmatrelvir/ritonavir and molnupiravir on post-COVID-19 outcomes among outpatients: a target trial emulation investigation
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
Emerging Microbes & Infections (2025)
Open Access
Yuchen Wei, Christopher Boyer, Katherine Min Jia, et al.
Emerging Microbes & Infections (2025)
Open Access
Prevention of post COVID-19 condition by early treatment with ensitrelvir in the phase 3 SCORPIO-SR trial
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
Antiviral Research (2024) Vol. 229, pp. 105958-105958
Open Access | Times Cited: 4
Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi, et al.
Antiviral Research (2024) Vol. 229, pp. 105958-105958
Open Access | Times Cited: 4
Colchicine—The Divine Medicine against COVID-19
Vanio Mitev
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 756-756
Open Access | Times Cited: 3
Vanio Mitev
Journal of Personalized Medicine (2024) Vol. 14, Iss. 7, pp. 756-756
Open Access | Times Cited: 3
Nirmatrelvir/ritonavir treatment and risk for postacute sequelae of COVID-19 in older Singaporeans
Liang En Wee, Jue Tao Lim, An Ting Tay, et al.
Clinical Microbiology and Infection (2024) Vol. 31, Iss. 1, pp. 93-100
Closed Access | Times Cited: 3
Liang En Wee, Jue Tao Lim, An Ting Tay, et al.
Clinical Microbiology and Infection (2024) Vol. 31, Iss. 1, pp. 93-100
Closed Access | Times Cited: 3
Evaluation of Glutathione in Spike Protein of SARS-CoV-2 Induced Immunothrombosis and Cytokine Dysregulation
Brandon Norris, Abraham Chorbajian, John Dawi, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 271-271
Open Access | Times Cited: 2
Brandon Norris, Abraham Chorbajian, John Dawi, et al.
Antioxidants (2024) Vol. 13, Iss. 3, pp. 271-271
Open Access | Times Cited: 2
The importance of including Long COVID outcomes when developing novel treatments for acute COVID-19
Chloe Connor, Holly A. Taylor
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 2
Chloe Connor, Holly A. Taylor
The Journal of Infectious Diseases (2024)
Open Access | Times Cited: 2
COVID-19 Booster Vaccination Status and Long COVID in the United States: A Nationally Representative Cross-Sectional Study
Jamie L. Romeiser, Kelsey Schoeneck
Vaccines (2024) Vol. 12, Iss. 6, pp. 688-688
Open Access | Times Cited: 2
Jamie L. Romeiser, Kelsey Schoeneck
Vaccines (2024) Vol. 12, Iss. 6, pp. 688-688
Open Access | Times Cited: 2
Effect of Paxlovid Treatment During Acute COVID-19 on Long COVID Onset: An EHR-Based Target Trial Emulation from the N3C and RECOVER Consortia
Alexander Preiss, Abhishek Bhatia, Leyna Aragon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Alexander Preiss, Abhishek Bhatia, Leyna Aragon, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Long COVID symptoms after 8-month recovery: persistent static lung hyperinflation associated with small airway dysfunction
Po‐Chun Lo, Jia‐Yih Feng, Yi‐Han Hsiao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Po‐Chun Lo, Jia‐Yih Feng, Yi‐Han Hsiao, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Speech as Public Choice Remedy
Irina D. Manta, Cassandra Burke Robertson, Zoë Robinson
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 1
Irina D. Manta, Cassandra Burke Robertson, Zoë Robinson
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 1
Persistent Neurological Deficits in Mouse PASC Reveal Antiviral Drug Limitations
Abhishek Kumar Verma, Shea A. Lowery, Li-Chin Lin, et al.
(2024)
Open Access | Times Cited: 1
Abhishek Kumar Verma, Shea A. Lowery, Li-Chin Lin, et al.
(2024)
Open Access | Times Cited: 1
COVID-19 vaccination modified the effect of nirmatrelvir–ritonavir on post-acute mortality and rehospitalization: a retrospective cohort study
Huwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Huwen Wang, Yuchen Wei, Guozhang Lin, et al.
Emerging Microbes & Infections (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Learning from Post COVID-19 condition for epidemic preparedness: a variable catalogue for future Post-Acute Infection Syndromes
Anna Górska, Lorenzo Maria Canziani, Eugenia Rinaldi, et al.
Clinical Microbiology and Infection (2024)
Closed Access | Times Cited: 1
Anna Górska, Lorenzo Maria Canziani, Eugenia Rinaldi, et al.
Clinical Microbiology and Infection (2024)
Closed Access | Times Cited: 1
Infectious Disease Updates for Primary Care
Denise J. McCulloch, Paul S. Pottinger
Medical Clinics of North America (2024) Vol. 108, Iss. 5, pp. 965-979
Closed Access
Denise J. McCulloch, Paul S. Pottinger
Medical Clinics of North America (2024) Vol. 108, Iss. 5, pp. 965-979
Closed Access
Oral antivirals for acute symptoms and post-acute sequelae in SARS-CoV-2 infection
Vincent Soriano, Víctor Moreno‐Torres
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1066-1067
Closed Access
Vincent Soriano, Víctor Moreno‐Torres
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 10, pp. 1066-1067
Closed Access
Real-World Effectiveness of Nirmatrelvir in Protecting Long COVID for Outpatient Adult Patients – A Large-Scale Observational Cohort Study from the RECOVER Initiative
Fei Wang, Chengxi Zang, Haoyang Li, et al.
Research Square (Research Square) (2024)
Open Access
Fei Wang, Chengxi Zang, Haoyang Li, et al.
Research Square (Research Square) (2024)
Open Access
Emerging small-molecule antiviral agents in long COVID prevention
Xiaomeng He, Xiang Zhang, Wu Zhong
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Xiaomeng He, Xiang Zhang, Wu Zhong
Frontiers in Pharmacology (2024) Vol. 15
Open Access
